Todd R. Daviau

Biography

 Todd Daviau, an accomplished scientific leader, brings almost 30 years of pharmaceutical experience and knowledge to CoreRx, as well as being one of principal founders. Prior to founding CoreRx, he served as Director of the Analytical and Pre-Formulation Laboratory for MDS Pharma Services in Tampa, FL. In this role, he directed the analytical group of over 20 scientists responsible for all the analytical, stability, and pre-formulation activities in support of over 75 stability, formulation and/or manufacturing projects. Dr. Daviau was also a strategic analytical team member with Nova Pharmaceuticals (later Guilford Pharmaceuticals), and involved in a number of NDA programs, including the development of Gliadel®. Todd is acknowledged as a creative leader focused on advancing projects with experience in multiple therapeutic areas. He is an expert in optimizing the drug discovery process through optimal resource allocation, process improvements and using scientific acumen to resolve complex project related issues. Todd brings a breadth of pharmaceutical experience, from drug discovery through research and development, analytical (R&D and QC.) and management experience in top-tier multinational pharmaceutical organizations. He is recognized as global, strategic thinker, with demonstrated ability to deliver pre-clinical and clinical candidates, within stringent timelines. Dr. Daviau holds a bachelor’s degree in Marine Biology and Chemistry, a PhD in Natural Product Chemistry and an MBA in Business Management.  

Research Interest

Dr. Daviau intrested  in Natural Product Chemistry and Business Management research